FitBit and coaching aim to boost exercise in prostate cancer patients

NCT ID NCT05755490

Completed Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a behavioral program called PROWESS for Black and Hispanic men with prostate cancer who are on hormone therapy (ADT). The program included video or in-person sessions with a psychologist or social worker and a FitBit to track activity. The goal was to see if the program could help men exercise more, reduce side effects, and improve quality of life. Only 14 people took part, so results are very preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral change intervention (PROWESS) with FitBit
What this could lead to: If successful, this could point toward a practical way to help prostate cancer patients on hormone therapy stay active and feel better.
What could go wrong: This is a very small pilot study with only 14 participants, so results may not apply to everyone. The program may not lead to lasting changes in exercise or quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER PROSTATIC NEOPLASMS

Contacts and locations

Locations

Massachusetts General Hospital Cancer Center

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.